Latest Articles

Publication Date
Acrivon reports 52% response rate in serous endometrial cancer trial By Investing.com - Investing.com Australia

Acrivon reports 52% response rate in serous endometrial cancer trial By Investing.com Investing.com Australia

Published: Jan. 8, 2026, 1:10 p.m.
Eutopic Endometrium Immune Changes Involved in Development and Progression of Endometriosis: A Review.

Numerous abnormalities of the endometriosis eutopic endometrium contribute to the initiation and development of ectopic lesions. It is also believed that among the complex causes of the disease, systemic immunological …

Published: Jan. 8, 2026, midnight
Characterization of the follicular fluid microbiome in endometriosis patients undergoing in vitro fertilization.

Endometriosis (EMs) is a common gynecological disorder associated with infertility. EMs patients often require assisted reproductive technology (ART) but exhibit lower success rates. This study aimed to characterize the follicular …

Published: Jan. 8, 2026, midnight
Navigating Complexity: Review and Updates of Endometriosis and Adenomyosis Imaging.

Endometriosis and adenomyosis are prevalent chronic inflammatory conditions that significantly impact reproductive-age women, leading to debilitating symptoms such as pelvic pain, dysmenorrhea, and infertility. Endometriosis is characterized by ectopic endometrial …

Published: Jan. 8, 2026, midnight
Robotic-assisted resection of parametrial endometriosis with ureterolysis of a medially distorted ureter using indocyanine green and near-infrared fluorescence.

Deep infiltrating endometriosis (DIE) is a severe form of endometriosis, with endometriotic implants that can invade several anatomical structures. The urinary tract is the second most common site for deep …

Published: Jan. 8, 2026, midnight
Active surveillance of an endometriosis-related, hormone-responsive pelvic adenosarcoma during pregnancy: A case report.

Extrauterine adenosarcomas are rare gynecologic malignancies that can arise within foci of pelvic endometriosis. They are often hormone mediated and thus are challenging to treat during pregnancy.

Published: Jan. 8, 2026, midnight
Digid announces nanoscale temperature and force sensors ready for mass deployment - Med-Tech Insights

Digid announces nanoscale temperature and force sensors ready for mass deployment Med-Tech Insights

Published: Jan. 7, 2026, 10:08 a.m.
Management of strangulated, perforated gastrothorax with resultant tension pneumothorax secondary to an iatrogenic diaphragmatic hernia: a case report.

Diaphragmatic hernias arise when a defect in the diaphragmatic musculotendinous framework allows the abnormal protrusion of abdominal contents into the thoracic cavity, which can be further complicated by visceral incarceration, …

Published: Jan. 7, 2026, midnight
Transcriptomic landscape of coexisting ovarian clear cell carcinoma and endometriosis: Insights into malignant transformation.

This study investigateted the malignant transformation of endometriosis (EMS) into ovarian clear cell carcinoma (OCCC) using spatial transcriptomics and single-cell RNA sequencing (scRNA-seq) integration. Tissues with coexisting EMS and OCCC …

Published: Jan. 7, 2026, midnight
Comparative safety profiles of spironolactone, eplerenone, and finerenone: a pharmacovigilance study based on FAERS data from 2004 to 2024.

Spironolactone, eplerenone, and finerenone are three commonly used mineralocorticoid receptor antagonists (MRAs) with cardioprotective and renoprotective effects. However, comparative real-world safety evaluations remain limited. This study aimed to assess and …

Published: Jan. 7, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!